A NSW Government website

On

Respiratory Medicine Research

The Department of Respiratory and Sleep Medicine at the Royal Prince Alfred Hospital is a leader in both translational and clinical research. Many of our researchers are recognised as national and international leaders in their field.

Our main goal is to advance our understanding and treatment of lung diseases and sleep-related disorders. We carry out diverse research including both investigator-led and industry-sponsored studies, and provide supervision and support for numerous Higher Degree by Research students.

Selected Grants

Amount awarded Grant and project details
$9,967,326 MRFF 2020 Rapid Applied Research Translation Grant Opportunity, 2022-2027
Scaling up infectious disease point-of-care testing for Indigenous people
Investigator: Fox G
 $6,458,052 NHMRC, 2019-2023
Ending Tuberculosis. A cluster RCT of community-wide universal testing and treatment for latent TB infection in high prevalence settings
Investigator: Fox G (CIB)
$4,773,516 NHMRC, 2022-2027
The FLIRT-TB study: A fluoroquinolone-based regimen to treat the commonest form of drug-resistant tuberculosis
Investigator: Fox G (CIA)
$4,250,000 MRFF - Rapid Applied Research Translation, 2020-2025
Pathway to the Elimination of Antibiotic-Resistant Tuberculosis in the Pacific: The PEARL study
Investigator: Fox G (CID)
$3,149,133 NHMRC Investigator Grant, 2022-2026
New directions in global tuberculosis control
Investigator: Fox G (CIA)
$2,542,500 NHMRC Centre of Research Excellence, 2023-2028
Interstitial Lung Disease, towards individualised care
Investigator: Corte TJ (CIA)
$2,498,607 NHMRC Centre of Research Excellence, 2017-2023
Centre for Research Excellence in Pulmonary Fibrosis
Investigator: Corte TJ (CIA)
$2,497,940 NHMRC Centre of Research Excellence, 2019-2023
Centre of Research Excellence in Tuberculosis Control on both sides of our border
Investigator: Fox G (CID)
$2,497,940 NHMRC Centre of Research Excellence, 2019-2023
Centre for Research Excellence in the accelerated implementation of new point-of-care technology for infectious diseases 
Investigator: Fox G (CIH)
 $2,216,631 MRFF, 2021-2025
Silicosis – Harnessing new ideas to conquer the re-emergence of an ancient lung disease – The SHIELD Study
Investigator: Corte T (CID)
$1,999,997 MRFF, 2023-2028
A Randomised Clinical Trial of Self Management Application in Pulmonary Fibrosis (REBUILD-SM Trial)
RPA Investigator: Corte TJ
$1,954,171 NHMRC, 2023-2027
Transforming outcomes for Interstitial Lung Disease
Investigator: Corte TJ (CIA)
 $1,828,446 MRFF, 2020-2025
The TELO-SCOPE study: Attenuating Telomere Attrition with Danazol. Is there Scope to Dramatically Improve Health Outcomes for Adults and Children with Pulmonary Fibrosis?
Investigator: Corte T (CIB)
$1,670,699 Lung Foundation Australia and Perpetual Impact, 2017-2023
Genetics Research in Idiopathic Pulmonary Fibrosis (GRIPF)
Investigator: Corte TJ, Dickinson J, et al.
$1,503,718 NHMRC, 2018-2023
Ambulatory oxygen for interstitial lung disease
Investigator: Corte TJ (CIC)
$980,415 MRFF 2020 Respiratory Medicine Clinical Trials Research on COVID-19, 2020-2023
IMPACT-ICO: Trials of Immuno-Modulatory Particles and Colchicine To Improve COVID-19 Outcomes
Investigator: Lau E (CIC)
$658,233 NHMRC, 2022-2023
Understanding Brain Cleaning in Obstructive Sleep Apnoea
Investigators: Phillips C, Postnova S, Butlin M, Wong K
$496,103 NHMRC, 2019-2023
Harnessing new mHealth technologies to Strengthen the Management of Multidrug-Resistant Tuberculosis in Vietnam: The V-SMART Trial
Investigator: Fox G (CIA)
$422,345 Jannsen Research Support, 2023-2027
PHSANZ Registry
Investigator: Lau E (CIA)
 USD $179,032  Cystic Fibrosis Foundation, 2021-2023
Stool and symptom testing in ColoREctal Evaluation for Neoplasia in Cystic Fibrosis (SCREEN-CF)
Investigator: Ooi K, Sivam S, Van Dorst J, Haber P, Mallitt K
$195,377 iCARE, 2022-2023
Silicosis Care Optimising future health care and support for people with silicosis
Investigator: Holland (CIA), Corte TJ, et al.
$90,000 Lung Foundation Australia and The University of Sydney, 2021-2024
Novel diagnostic techniques in interstitial lung disease
Investigator: Glenn L

Our Publications

2022

Professor Tamera Corte
Zheng Q, Cox IA, de Graaff B, Campbell JA, Corte TJ, Glaspole I, Navaratnam V, Hopkins P, Zappala C, Ahmad H, Zhao T, Macansh S, Walters EH, Palmer AJ. The relative contribution of co-morbidities to health-related quality of life of people with idiopathic pulmonary fibrosis using the Assessment of Quality of Life-8-Dimension multi-attribute utility instrument. Qual Life Res. 2022 Dec 26. doi: 10.1007/s11136-022-03331-8. Epub ahead of print. PMID: 36572788.
Barnes H, Humphries SM, George PM, Assayag D, Glaspole I, Mackintosh JA, Corte TJ, Glassberg M, Johannson KA, Calandriello L, Felder F, Wells A, Walsh S. Machine learning in radiology: the new frontier in interstitial lung diseases. Lancet Digit Health. 2023 Jan;5(1):e41-e50. doi: 10.1016/S2589-7500(22)00230-8. Epub 2022 Dec 12. PMID: 36517410.
Barnes H, Chambers D, Grainge C, Corte TJ, Bastiampillai S, Frenkel S, Westall G, Collard H, Glaspole I. Clinical utility of a standardized chronic hypersensitivity pneumonitis exposure questionnaire. Respirology. 2022 Nov 6. doi: 10.1111/resp.14404. Epub ahead of print. PMID: 36336654.
Cox IA, de Graaff B, Ahmed H, Campbell J, Otahal P, Corte TJ, Moodley Y, Goh N, Hopkins P, Macansh S, Walters EH, Palmer AJ. The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness study. Eur J Health Econ. 2022 Oct 27. doi: 10.1007/s10198-022-01538-7. Epub ahead of print. PMID: 36289130.
Lucas SEM, Raspin K, Mackintosh J, Glaspole I, Reynolds PN, Chia C, Grainge C, Kendall P, Troy L, Schwartz DA, Wood-Baker R, Walsh SLF, Moodley Y, Robertson J, Macansh S, Walters EH, Chambers D, Corte TJ, Dickinson JL. Preclinical interstitial lung disease in relatives of familial pulmonary fibrosis patients. Pulmonology. 2022 Oct 7:S2531-0437(22)00213-6. doi: 10.1016/j.pulmoe.2022.09.002. Epub ahead of print. PMID: 36216738.
Glenn LM, Troy LK, Corte TJ. Diagnosing interstitial lung disease by multidisciplinary discussion: A review. Front Med (Lausanne). 2022 Sep 21;9:1017501. doi: 10.3389/fmed.2022.1017501. PMID: 36213664; PMCID: PMC9532594.
Conway Morris A, Kohler K, De Corte T, Ercole A, De Grooth HJ, Elbers PWG, Povoa P, Morais R, Koulenti D, Jog S, Nielsen N, Jubb A, Cecconi M, De Waele J; ESICM UNITE COVID investigators. Correction: Co-infection and ICU-acquired infection in COVID-19 ICU patients: a secondary analysis of the UNITE-COVID data set. Crit Care. 2022 Aug 17;26(1):249. doi: 10.1186/s13054-022-04124-8. Erratum for: Crit Care. 2022 Aug 3;26(1):236. PMID: 35978317; PMCID: PMC9383662.
Cottin V, Selman M, Inoue Y, Wong AW, Corte TJ, Flaherty KR, Han MK, Jacob J, Johannson KA, Kitaichi M, Lee JS, Agusti A, Antoniou KM, Bianchi P, Caro F, Florenzano M, Galvin L, Iwasawa T, Martinez FJ, Morgan RL, Myers JL, Nicholson AG, Occhipinti M, Poletti V, Salisbury ML, Sin DD, Sverzellati N, Tonia T, Valenzuela C, Ryerson CJ, Wells AU. Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement. Am J Respir Crit Care Med. 2022 Aug 15;206(4):e7-e41. doi: 10.1164/rccm.202206-1041ST. PMID: 35969190.
Cox IA, Campbell J, de Graaff B, Otahal P, Corte TJ, Moodley Y, Hopkins P, Macansh S, Walters EH, Palmer AJ. Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8D. Qual Life Res. 2022 Aug 4. doi:10.1007/s11136-022-03205-z. Epub ahead of print. PMID: 35927542.
Conway Morris A, Kohler K, De Corte T, Ercole A, De Grooth HJ, Elbers PWG, Povoa P, Morais R, Koulenti D, Jog S, Nielsen N, Jubb A, Cecconi M, De Waele J; ESICM UNITE COVID investigators. Co-infection and ICU-acquired infection in COIVD-19 ICU patients: a secondary analysis of the UNITE-COVID data set. Crit Care. 2022 Aug 3;26(1):236. doi: 10.1186/s13054-022-04108-8. Erratum in: Crit Care. 2022 Aug 17;26(1):249. PMID: 35922860; PMCID: PMC9347163.
Humphries SM, Mackintosh JA, Jo HE, Walsh SLF, Silva M, Calandriello L, Chapman S, Ellis S, Glaspole I, Goh N, Grainge C, Hopkins PMA, Keir GJ, Moodley Y, Reynolds PN, Walters EH, Baraghoshi D, Wells AU, Lynch DA, Corte TJ. Quantitative computed tomography predicts outcomes in idiopathic pulmonary fibrosis. Respirology. 2022 Dec;27(12):1045-1053. doi: 10.1111/resp.14333. Epub 2022 Jul 25. PMID: 35875881; PMCID: PMC9796832.
Molina-Molina M, Kreuter M, Cottin V, Corte TJ, Gilberg F, Kirchgaessler KU, Axmann J, Maher TM. Efficacy of Pirfenidone vs. Placebo in Unclassifiable Interstitial Lung Disease, by Surgical Lung Biopsy Status: Data From a post- hoc Analysis. Front Med (Lausanne). 2022 Jun 17;9:897102. doi:10.3389/fmed.2022.897102. PMID: 35783648; PMCID: PMC9247211.
Walsh SLF, Mackintosh JA, Calandriello L, Silva M, Sverzellati N, Larici AR, Humphries SM, Lynch DA, Jo HE, Glaspole I, Grainge C, Goh N, Hopkins PMA, Moodley Y, Reynolds PN, Zappala C, Keir G, Cooper WA, Mahar AM, Ellis S, Wells AU, Corte TJ. Deep Learning-based Outcome Prediction in Progressive Fibrotic Lung Disease Using High-Resolution Computed Tomography. Am J Respir Crit Care Med. 2022 Oct 1;206(7):883-891. doi: 10.1164/rccm.202112-2684OC. PMID: 35696341.
Richeldi L, Azuma A, Cottin V, Hesslinger C, Stowasser S, Valenzuela C, Wijsenbeek MS, Zoz DF, Voss F, Maher TM; 1305-0013 Trial Investigators. Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis. N Engl J Med. 2022 Jun 9;386(23):2178-2187. doi: 10.1056/NEJMoa2201737. Epub 2022 May 15. PMID: 35569036.
Seth I, Bhagavata Srinivasan SP, Bulloch G, Yi DS, Frankel A, Hsu K, Passam F, Garsia R, Corte TJ. Diffuse alveolar haemorrhage as a rare complication of antiphospholipid syndrome. Respirol Case Rep. 2022 Apr 5;10(5):e0948. doi: 10.1002/rcr2.948. PMID: 35414937; PMCID: PMC8980908.
Cottin V, Tomassetti S, Valenzuela C, Walsh SLF, Antoniou KM, Bonella F, Brown KK, Collard HR, Corte TJ, Flaherty KR, Johannson KA, Kolb M, Kreuter M, Inoue Y, Jenkins RG, Lee JS, Lynch DA, Maher TM, Martinez FJ, Molina-Molina M, Myers JL, Nathan SD, Poletti V, Quadrelli S, Raghu G, Rajan SK, Ravaglia C, Remy-Jardin M, Renzoni E, Richeldi LK, Spagnolo P, Troy L, Wijsenbeek M, Wilson KC, Wuyts W, Wells AU, Ryerson CJ. Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group Perspective. Am J Respir Crit Care Med. 2022 Aug 1;206(3):247-259. doi: 10.1164/rccm.202111-2607PP. PMID: 35353660.
Zheng Q, Cox IA, Campbell JA, Xia Q, Otahal P, de Graaff B, Corte TJ, Teoh AKY, Walters EH, Palmer AJ. Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis. ERJ Open Res. 2022 Mar 14;8(1):00591-2021. doi: 10.1183/23120541.00591-2021. PMID: 35295232; PMCID: PMC8918939.
Christian K, Hey-Cunningham A, Corte T, Goh N, Jaffar J, Reynolds P, Teoh A, Troy L. Establishing CREATE: lessons learned in setting up a training environment for early-career researchers in respiratory medicine. BMC Med Educ. 2022 Mar 1;22(1):136. doi: 10.1186/s12909-022-03169-1. PMID: 35232441; PMCID: PMC8886858.
Zanframundo G, Faghihi-Kashani S, Scirè CA, Bonella F, Corte TJ, Doyle TJ, Fiorentino D, Gonzalez-Gay MA, Hudson M, Kuwana M, Lundberg IE, Mammen A, McHugh N, Miller FW, Monteccucco C, Oddis CV, Rojas-Serrano J, Schmidt J, Selva-O'Callaghan A, Werth VP, Sakellariou G, Aggarwal R, Cavagna L. Defining anti-synthetase syndrome: a systematic literature review. Clin Exp Rheumatol. 2022 Feb;40(2):309-319. doi: 10.55563/clinexprheumatol/8xj0b9. Epub 2022 Feb 25. PMID: 35225224.
Kreuter M, Maher TM, Corte TJ, Molina-Molina M, Axmann J, Gilberg F, Kirchgaessler KU, Cottin V. Pirfenidone in Unclassifiable Interstitial Lung Disease: A Subgroup Analysis by Concomitant Mycophenolate Mofetil and/or Previous Corticosteroid Use. Adv Ther. 2022 Feb;39(2):1081-1095. doi: 10.1007/s12325-021-02009-w. Epub 2021 Dec 22. PMID: 34936057; PMCID: PMC8866297.
Cox IA, Otahal P, de Graaff B, Corte TJ, Moodley Y, Zappala C, Glaspole I, Hopkins P, Macansh S, Walters EH, Palmer AJ. Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in Australia. Respirology. 2022 Mar;27(3):209-216. doi: 10.1111/resp.14194. Epub 2021 Dec 21. PMID: 34935240. 
Tikellis G, Corte TJ, Teoh AKY, Glaspole IN, Macansh S, Holland AE. Barriers and facilitators to best care for idiopathic pulmonary fibrosis in Australia. Respirology. 2022 Jan;27(1):76-84. doi: 10.1111/resp.14185. Epub 2021 Nov 15. PMID: 34783108.
Clynick B, Corte TJ, Jo HE, Stewart I, Glaspole IN, Grainge C, Maher TM, Navaratnam V, Hubbard R, Hopkins PMA, Reynolds PN, Chapman S, Zappala C, Keir GJ, Cooper WA, Mahar AM, Ellis S, Goh NS, De Jong E, Cha L, Tan DBA, Leigh L, Oldmeadow C, Walters EH, Jenkins RG, Moodley Y. Biomarker signatures for progressive idiopathic pulmonary fibrosis. Eur Respir J. 2022 Mar 31;59(3):2101181. doi: 10.1183/13993003.01181-2021. PMID: 34675050.
Hunninghake GM, Goldin JG, Kadoch MA, Kropski JA, Rosas IO, Wells AU, Yadav R, Lazarus HM, Abtin FG, Corte TJ, de Andrade JA, Johannson KA, Kolb MR, Lynch DA, Oldham JM, Spagnolo P, Strek ME, Tomassetti S, Washko GR, White ES; ILA Study Group. Detection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey Initiative. Chest. 2022 Feb;161(2):470-482. doi: 10.1016/j.chest.2021.06.035. Epub 2021 Jun 29. PMID: 34197782.
Teoh AKY, Holland AE, Morisset J, Flaherty KR, Wells AU, Walsh SLF, Glaspole I, Wuyts WA, Corte TJ; ILD MDM Delphi Collaborators. Essential Features of an Interstitial Lung Disease Multidisciplinary Meeting: An International Delphi Survey. Ann Am Thorac Soc. 2022 Jan;19(1):66-73. doi:10.1513/AnnalsATS.202011-1421OC. PMID: 34191689.
Professor Gregory Fox
Marks, G., Ho, J., Nguyen, P., Nguyen, T., Boi, K., Nhung, N., Nguyen, H., Nguyen, L., Garden, F., Fox, G. (2022). A Direct Measure of Tuberculosis Incidence - Effect of Community Screening. New England Journal of Medicine, 386(14), 1380-1382.
Romanowski, K., Oravec, A., Billingsley, M., Shearer, K., Gupte, A., Huaman, M., Fox, G., Golub, J., Johnston, J. (2022). A scoping review of interventions to mitigate common non-communicable diseases among people with TB. International Journal of Tuberculosis and Lung Disease, 26(11), 1016-1022.
Huang, W., Marks, G., Pham, N., Nguyen, T., Nguyen, T., Vu, V., Nguyen, V., Jan, S., Negin, J., Ngo, Q., Fox, G. (2022). A smoking quitline integrated with clinician counselling at outpatient health facilities in Vietnam: a single-arm prospective cohort study. BMC Public Health, 22(1), 739. 
Redwood, L., Mitchell, E., Nguyen, T., Viney, K., Duong, L., Pham, H., Nguyen, B., Nguyen, V., Fox, G. (2022). Adaptation and validation of the Van Rie tuberculosis stigma scale in Vietnam. International Journal of Infectious Diseases, 114, 97-104. 
Ngoc Yen, P., Obeid, M., Quy Chau, N., Van Giap, V., Viet Nhung, N., Yen, N., Thi Ha, B., Nguyen, T., Marks, G., Freeman, B., Negin, J., Fox, G. (2022). Behaviors and Attitudes Toward Smoking Among Health Care Workers at Health Facilities in 4 Provinces of Vietnam: A Representative Cross-Sectional Survey. Asia-Pacific Journal of Public Health, 34(1), 79-86. 
Alffenaar, J., Stocker, S., Davies Forsman, L., Garcia-Prats, A., Heysell, S., Aarnoutse, R., Akkerman, O., Aleksa, A., van Altena, R., de Oata, W., Cho, J., Fox, G., Kim, H., Marais, B., et al (2022). Clinical standards for the dosing and management of TB drugs. International Journal of Tuberculosis and Lung Disease, 26(6), 483-499. 
Pahlman, K., Fehross, A., Fox, G., Silva, D. (2022). Ethical health security in the age of antimicrobial resistance. BMJ Global Health, 7(1), e007407-1-e007407-11. 
Velen, K., Nguyen, V., Nguyen, B., Dang, T., Nguyen, H., Vu, D., Do, T., Pham Duc, C., Nguyen, H., Pham, H., Marais, B., Britton, W., Beardsley, J., Negin, J., Fox, G., et al (2022). Harnessing new mHealth technologies to Strengthen the Management of Multidrug-Resistant Tuberculosis in Vietnam (V-SMART trial): A protocol for a randomised controlled trial. BMJ Open, 12(6). 
Zawahir, M., Le, H., Nguyen, T., Beardsley, J., Dang, A., Bernays, S., Viney, K., Cao, T., Drabarek, D., Tran, H., Marais, B., Negin, J., Marks, G., Fox, G., et al (2022). Inappropriate supply of antibiotics for common viral infections by community pharmacies in Vietnam: A standardised patient survey. The Lancet Regional Health. Western Pacific, 23, 100447.
Martinez, L., Cords, O., Liu, Q., Acuna-Villaorduna, C., Bonnet, M., Fox, G., Carvalho, A., Chan, P., Croda, J., Hill, P., et al (2022). Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis. The Lancet Global Health, 10(9), e1307-e1316. 
Coleman, M., Hill, J., Timeon, E., Tonganibeia, A., Eromanga, B., Islam, T., Trauer, J., Chambers, S., Christensen, A., Fox, G., Britton, W., Marais, B., et al (2022). Population-wide active case finding and prevention for tuberculosis and leprosy elimination in Kiribati: the PEARL study protocol. BMJ Open, 12(4), e055295-1-e055295-10. 
Wrohan, I., Nguyen, T., Nguyen, V., Nguyen, B., Hoang, T., Nguyen, P., Velen, K., Marks, G., Fox, G. (2022). Predictors of treatment outcomes among patients with multidrug-resistant tuberculosis in Vietnam: a retrospective cohort study. BMC Infectious Diseases, 22(1), 68. 
Callum, J., Nguyen, P., Martinez, E., Nguyen, V., Garden, F., Nhung, N., Nguyen, T., Nguyen, H., Nguyen, S., Luu, K., Fox, G., et al (2022). Prevalence and genetic basis of first-line drug resistance of Mycobacterium tuberculosis in Ca Mau, Vietnam. ERJ Open Research, 8(4). 
Hasan, T., Nguyen, V., Nguyen, H., Nguyen, T., Le, H., Pham, C., Do, N., Nguyen, P., Beardsley, J., Marks, G., Fox, G. (2022). Retrospective Cohort Study of Effects of the COVID-19 Pandemic on Tuberculosis Notifications, Vietnam, 2020. Emerging Infectious Diseases, 28(3), 684-692.
Coorey, N., Kensitt, L., Davies, J., Keller, E., Sheel, M., Chani, K., Barry, S., Boyd, R., Denholm, J., Watts, K., Fox, G., Marais, B., Viney, K., et al (2022). Risk factors for TB in Australia and their association with delayed treatment completion. International Journal of Tuberculosis and Lung Disease, 26(5), 399-405.
Trinh, D., McKinn, S., Nguyen, A., Fox, G., Anh Thu, N., Bernays, S. (2022). Uneven stigma loads: Community interpretations of public health policies, evidence and inequities in shaping Covid-19 stigma in Vietnam. SSM - Population Health, 20.
Dr Laura Glenn
Glenn LM, Troy LK, Corte TJ. Diagnosing interstitial lung disease by multidisciplinary discussion: a review. Front Med. 2022;9:1017501.
Dr Helen Jo 
Clynick B, Corte TJ, Jo HE, Stewart I, Glaspole IN, Grainge C, Maher TM, Navaratnam V, Hubbard R, Hopkins PMA, Reynolds PN, Chapman S, Zappala C, Keir GJ, Cooper WA, Mahar AM, Ellis S, Goh NS, De Jong E, Cha L, Tan DBA, Leigh L, Oldmeadow C, Walters EH, Jenkins RG, Moodley Y. Biomarker signatures for progressive idiopathic pulmonary fibrosis. Eur Respir J. 2022 Mar 31;59(3):2101181. doi: 10.1183/13993003.01181-2021. Print 2022 Mar.
Bell JM, Sivam S, Dentice RL, Dwyer TJ, Jo HE, Lau EM, Munoz PA, Nolan SA, Taylor NA, Visser SK, Yozghatlian VA, Wong KK. Quality of home spirometry performance amongst adults with cystic fibrosis. J Cyst Fibros. 2022 Jan;21(1):84-87. doi: 10.1016/j.jcf.2021.10.012. Epub 2021 Nov 10.
Walsh SLF, Mackintosh JA, Calandriello L, Silva M, Sverzellati N, Larici AR, Humphries SM, Lynch DA, Jo HE, Glaspole I, Grainge C, Goh N, Hopkins PMA, Moodley Y, Reynolds PN, Zappala C, Keir G, Cooper WA, Mahar AM, Ellis S, Wells AU, Corte TJ. Deep Learning-based Outcome Prediction in Progressive Fibrotic Lung Disease Using High-Resolution Computed Tomography.  Am J Respir Crit Care Med. 2022 Oct 1;206(7):883-891. doi: 10.1164/rccm.202112-2684OC.
Humphries SM, Mackintosh JA, Jo HE, Walsh SLF, Silva M, Calandriello L, Chapman S, Ellis S, Glaspole I, Goh N, Grainge C, Hopkins PMA, Keir GJ, Moodley Y, Reynolds PN, Walters EH, Baraghoshi D, Wells AU, Lynch DA, Corte TJ. Quantitative computed tomography predicts outcomes in idiopathic pulmonary fibrosis. Respirology. 2022 Dec;27(12):1045-1053. doi: 10.1111/resp.14333. Epub 2022 Jul 25.
Lin A, Wong K, Visser SK, Jo H, Al-Hindawi Y, Kosbab-Jackson K, Cocks M, Volovets A, Haber P, Hammond K, Taylor N, Yozghatlian V, Lau EM, Marshall NS, Aquino-Salomon T, Sivam S. Diagnosis of cystic fibrosis in adults: Australian Cystic Fibrosis Data Registry data, 2000-2019. Med J Aust. 2022 Dec 1. doi: 10.5694/mja2.51797. 
Associate Professor Edmund Lau
Kearney K, Lau EM. Inherited thrombophilia in Chinese CTEPH patients: a rather common finding an uncommon condition. JACC Asia 2022;2:256-257.
Bell JM, Sivam S, Dentice RL, Dwyer TJ, Jo HE, Lau EM, Munoz PA, Nolan SA, Taylor NA, Visser SK, Yozghatlian VA, Wong KK. Quality of home spirometry perform ace amongst adults with cystic fiberosis. J Cyst Fibros 2022;21:84-87
Othman F, Bailey B, Collins N, Lau EM, Tanous D, Rao K, Celermajer D, Cordina R. Platypnoea-orthodeoxia syndrome in patent foramen ovale without pulmonary hypertension or major lung disease. J Am Heart Assoc. 2022;11:e024609.
Associate Professor Amanda Piper
Chang JL, Goldberg AN, ...  Piper AJ, et al.  International consensus statement on obstructive sleep apnea. Int Forum Allergy Rhinol. 2022 Sep 6.
Sivam S, Wang D, Wong KKH, Piper AJ, Zheng YZ, Gauthier G, Hockings C, McGuinness O, Menadue C, Melehan K, Cooper S, Hilmisson H, Phillips CL, Thomas RJ, Yee BJ, Grunstein RR. Cardiopulmonary coupling and serum cardiac biomarkers in obesity hypoventilation syndrome and obstructive sleep apnea with morbid obesity. J Clin Sleep Med. 2022 Apr 1;18(4):1063-1071.
Dennis CJ, Menadue C, Schneeberger T, Leitl D, Schoenheit-Kenn U, Harmer AR, Barnes DJ, Koczulla AR, Kenn K, Alison JA. Perceptions of Noninvasive Ventilation During Exercise in Noninvasive Ventilation-Naïve Patients With COPD. Respir Care. 2022 May;67(5):543-552
Qu Y, Milross M, McGuiness O, Menadue C, Piper AJ. Survey of home cleaning practices with noninvasive ventilation equipment. Cardiopulmonary Physical Therapy Journal.
Dr Sheila Sivam
Chetwood J, Koh C, Sivam S and Volovets A. Surgical Considerations in Cystic Fibrosis: What every general surgeon needs to know. ANZ Journal of Surgery. Oct 2022; 92 (10): 2425-2432.
Gudka SG, Haynes E, Scotney J, Mukherjee S, Frenkel S, Sivam S, Swieca J, Chamula K, Cunnington D and Saini B. Narcolepsy: comorbidities, complexities and future directions. Sleep Medicine Reviews. Oct 2022; 65: 101669.
Gardiner A, Volovets A, Haber P, Jo HE, Visser SK, Yozghatlian VA, Taylor N, Nolan S, Dentice R, Malouf M, Marinelli T and Sivam S. ELX/TEZ/IVA use in Cystic Fibrosis Liver Disease: Is the perspective of improved lung function worth the risk? Journal of Cystic Fibrosis. Sep 2022; 21(5): 881-884.
Bell J, Sivam S, Dentice R, Dwyer T, Jo H, Lau E, Munoz P, Nolan S, Taylor N, Visser S, Yozghatlian, and Wong, K. Quality of home spirometry performance amongst adults with Cystic Fibrosis. Journal of Cystic Fibrosis. Jan 2022; 21(1): 84-87.
Professor Paul Torzillo
Chang AB, Bell SC, Byrnes CA, Dawkins P, Holland AE, Kennedy E, King PT, Laird P, Mooney S, Morgan L, Parsons M, Poot B, Toombs M, Torzillo PJ, Grimwood K. Thoracic Society of Australia and New Zealand (TSANZ) position statement on chronic suppurative lung disease and bronchiectasis in children, adolescents and adults in Australia and New Zealand. Respirology. 2023 Apr;28(4):339-349. 
Leach AJ, Wilson N, Arrowsmith B, Beissbarth J, Mulholland EK, Santosham M, Torzillo PJ, McIntyre P, Smith-Vaughan H, Chatfield MD, Lehmann D, Binks M, Chang AB, Carapetis J, Krause V, Andrews R, Snelling T, Skull SA, Licciardi PV, Oguoma VM, Morris PS. Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trials. Lancet Infect Dis. 2022 Sep;22(9):1374-1387.
McCallum GB, Fong SM, Grimwood K, Nathan AM, Byrnes CA, Ooi MH, Nachiappan N, Saari N, Morris PS, Yeo TW, Ware RS, Elogius BW, Oguoma VM, Yerkovich ST, de Bruyne J, Lawrence KA, Lee B, Upham JW, Torzillo PJ, Chang AB. Extended Versus Standard Antibiotic Course Duration in Children <5 Years of Age Hospitalized With Community-acquired Pneumonia in High-risk Settings: Four-week Outcomes of a Multicenter, Double-blind, Parallel, Superiority Randomized Controlled Trial. Pediatr Infect Dis J. 2022 Jul 1;41(7):549-555. 
Chang AB, Toombs M, Chatfield MD, Mitchell R, Fong SM, Binks MJ, Smith-Vaughan H, Pizzutto SJ, Lust K, Morris PS, Marchant JM, Yerkovich ST, O'Farrell H, Torzillo PJ, Maclennan C, Simon D, Unger HW, Ellepola H, Odendahl J, Marshall HS, Swamy GK, Grimwood K. Study Protocol for Preventing Early-Onset Pneumonia in Young Children Through Maternal Immunisation: A Multi-Centre Randomised Controlled Trial (PneuMatters). Front Pediatr. 2022 Jan 17;9:781168. 
Associate Professor Lauren Troy
Raghu G, Remy-Jardin M, Richeldi L...Troy LK et al. Idiopathic Pulmonary Fibrosis (an update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS / ERS / JRS / ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2022.  
Troy LK and Williamson JP. Invited editorial: Mediastinal cryobiopsy: safe and effective but in whom and when? Lancet Respir Med. 2022.
Solomon JJ, Danoff S, Woodhead F... Troy L.. Rosas I. A Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease. Lancet Respir Med. 2022.
Glenn LM, Troy LK and Corte TJ. Diagnosing Interstitial Lung Disease by Multidisciplinary Discussion: A Review. Frontiers in Medicine. 2022.
Lucas SEM, Raspin K, Mackintosh J ... Troy L et al.  Preclinical interstitial lung disease in relatives of familial pulmonary fibrosis patients. Pulmonology. 2022.
Korevaar DA, Colella S, Fally M, ... Troy LK, et al. European Respiratory Society guidelines on transbronchial lung cryobiopsy in the diagnosis of interstitial lung diseases. Eur Respir J.  2022.
Marinescu D-C, Raghu G, Remy-Jardin M ... Troy LK, et al. Integration and application of clinical practice guidelines for the diagnosis of idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis. Chest. 2022.
Kheir F, Becerra JPU, Bissell B, ... Troy L, et al. Transbronchial lung cryobiopsy in patients with interstitial lung disease: A systematic review. Ann Am Thorac Soc. 2022
Cottin V, Tomassetti S, Valenzuela C... Troy L et al. Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group Perspective. Am J Respir Crit Care Med. 2022.
Christian K, Hey-Cunningham A, Corte T...Troy L. Establishing CREATE: lessons learned in setting up a training environment for early-career researchers in respiratory medicine. BMC Med Ed. 2022
Dr Simone Visser
Bell JM, Sivam S, Dentice RL, Dwyer TJ, Jo HE, Lau EM, Munoz PA, Nolan SA, Taylor NA, Visser SK, Yozghatlian VA, Wong KK. Quality of home spirometry performance amongst adults with cystic fibrosis. J Cyst Fibros. 2022 Jan;21(1):84-87. doi: 10.1016/j.jcf.2021.10.012. Epub 2021 Nov 10.
Lin A, Wong K, Visser SK, Jo H, Al-Hindawi Y, Kosbab-Jackson K, Cocks M, Volovets A, Haber P, Hammond K, Taylor N, Yozghatlian V, Lau EM, Marshall NS, Aquino-Salomon T, Sivam S. Diagnosis of cystic fibrosis in adults: Australian Cystic Fibrosis Data Registry data, 2000-2019. Med J Aust. 2022 Dec 1. doi: 10.5694/mja2.51797.
Gardiner A, Volovets A, Haber P, Jo HE, Visser SK, Yozghatlian VA, Taylor N, Nolan S, Dentice R, Malouf M, Marinelli T and Sivam S. ELX/TEZ/IVA use in Cystic Fibrosis Liver Disease: Is the perspective of improved lung function worth the risk? J Cyst Fibros. Sep 2022; 21(5): 881-884
Associate Professor Keith Wong
Altree, T. J., Bartlett, D. J., Marshall, N. S., Hoyos, C. M., Phillips, C. L., Birks, C., . . . Cayanan, E. A. (2022). Predictors of weight loss in obese patients with obstructive sleep apnea. Sleep and Breathing, 26(2), 753-762. 
Basheti, M. M., Tran, M., Wong, K., Gordon, C., Grunstein, R., & Saini, B. (2022). Australian consultant pharmacists' potential roles in sleep health care: Exploring a new avenue for improving the management of insomnia. Behavioral Sleep Medicine, 20(5), 622-637. 
Bell, J. M., Sivam, S., Dentice, R. L., Dwyer, T. J., Jo, H. E., Lau, E. M., . . . Wong, K. K. (2022). Quality of home spirometry performance amongst adults with cystic fibrosis. Journal of Cystic Fibrosis, 21(1), 84-87. 
D'Rozario, A. L., Hoyos, C. M., Wong, K. K. H., Unger, G., Kim, J. W., Vakulin, A., . . . Grunstein, R. R. (2022). Improvements in cognitive function and quantitative sleep electroencephalogram in obstructive sleep apnea after six months of continuous positive airway pressure treatment. Sleep, 45(6) 
McLean, A. E. B., Kao, S. C., Barnes, D. J., Wong, K. K. H., Scolyer, R. A., Cooper, W. A., & Kohonen-Corish, M. R. J. (2022). The emerging role of the lung microbiome and its importance in non-small cell lung cancer diagnosis and treatment. Lung Cancer, 165, 124-132. 
Sivam, S., Wang, D., Wong, K. K. H., Piper, A. J., Zheng, Y. Z., Gauthier, G., . . . Grunstein, R. R. (2022). Cardiopulmonary coupling and serum cardiac biomarkers in obesity hypoventilation syndrome and obstructive sleep apnea with morbid obesity. Journal of Clinical Sleep Medicine, 18(4), 1063-1071. 
Vakulin, A., Green, M. A., D'Rozario, A. L., Stevens, D., Openshaw, H., Bartlett, D., . . . Rae, C. D. (2022). Brain mitochondrial dysfunction and driving simulator performance in untreated obstructive sleep apnea. Journal of Sleep Research, 31(2): e13482.
Professor Brendon Yee
Judge DJ, Miller CB, Bartlett DJ, Jomaa I, Wong KKW, Saini B, Semsarian CR, Espie CA, Kyle SD, Grunstein RR, Yee BJ, Marshall NS. Armodafinil to reduce the sleepiness related side-effects of sleep restriction therapy being used to treat insomnia disorder: An open label clinical trial pilot study compared with historical controls. J Sleep Res. 2023 Feb;32(1):e13699. doi: 10.1111/jsr.13699. Epub 2022 Aug 24. PMID: 36003019.
Aishah A, Loffler KA, Toson B, Mukherjee S, Adams RJ, Altree TJ, Ainge-Allen HW, Yee BJ, Grunstein RR, Carberry JC, Eckert DJ. One Month Dosing of Atomoxetine plus Oxybutynin in Obstructive Sleep Apnea: A Randomized, Placebo- controlled Trial. Ann Am Thorac Soc. 2022 Dec 20. doi: 10.1513/AnnalsATS.202206-492OC. 
Stranks L, Ellender CM, Wong K, Naqvi H, Grunstein R, Yee BJ, Sivam S. Retrospective cohort study of hypersomnias of central origin from two Australian tertiary sleep disorders services. Intern Med J. 2022 Aug 31. doi: 10.1111/imj.15920. Epub ahead of print. PMID: 36043439.
Hoyos CM, Cross NE, Terpening Z, D'Rozario AL, Yee BJ, LaMonica H, Marshall NS, Grunstein RR, Naismith SL. Continuous Positive Airway Pressure for Cognition in Sleep Apnea and Mild Cognitive Impairment: A Pilot Randomized Crossover Clinical Trial. Am J Respir Crit Care Med. 2022 Jun 15;205(12):1479-1482. doi: 10.1164/rccm.202111-2646LE. PMID: 35584294.
Altree TJ, Bartlett DJ, Marshall NS, Hoyos CM, Phillips CL, Birks C, Kanagaratnam A, Mullins A, Serinel Y, Wong KKH, Yee BJ, Grunstein RR, Cayanan EA. Predictors of weight loss in obese patients with obstructive sleep apnea. Sleep Breath. 2022 Jun;26(2):753-762. doi: 10.1007/s11325-021-02455-4. Epub 2021 Aug 6. PMID: 34357505.
Sivam S, Wang D, Wong KKH, Piper AJ, Zheng YZ, Gauthier G, Hockings C, McGuinness O, Menadue C, Melehan K, Cooper S, Hilmisson H, Phillips CL, Thomas RJ, Yee BJ, Grunstein RR. Cardiopulmonary coupling and serum cardiac biomarkers in obesity hypoventilation syndrome and obstructive sleep apnea with morbid obesity. J Clin Sleep Med. 2022 Apr 1;18(4):1063-1071. doi: 10.5664/jcsm.9804. PMID: 34879904; PMCID: PMC8974389.
Phillips CL, Cayanan EA, Yee BJ. Predicting Weight-Loss Effects on Obstructive Sleep Apnea and Cardiometabolic Health: In Search of the Craniofacial "Holy Grail". Am J Respir Crit Care Med. 2022 Mar 15;205(6):614-616. doi: 10.1164/rccm.202112-2750ED. PMID: 35085472.
Zheng Y, Yee BJ, Wong K, Grunstein R, Piper A. A pilot randomized trial comparing CPAP vs bilevel PAP spontaneous mode in the treatment of hypoventilation disorder in patients with obesity and obstructive airway disease. J Clin Sleep Med. 2022 Jan 1;18(1):99-107. doi: 10.5664/jcsm.9506. PMID: 34170241; PMCID: PMC8807907.